- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
-
ESG profile
- Media
- Partners
- Contact Us
Dr. Reddy's in the news
-
Economic Times - Pg 12
Click Here for the Complete Story [PDF Format] -
From Russia, with love
Click Here for the Complete Story [PDF Format] -
A recovery is underway at Dr. Reddy’s: results from US-business tweaks and CEO’s hawk eye on returns
Click Here for the Complete Story [PDF Format] -
How to fix Indian pharma's Chinese import problem
Click Here for the Complete Story [PDF Format] -
INTERVIEW: SATISH REDDY, chairman, Dr Reddy's Laboratories - 'Focus on API industry, cutting imports need of the hour'
Click Here for the Complete Story [PDF Format] -
Indian healthcare reforms offers thriving pharmaceutical market opportunities: Deepak Sapra
Click Here for the Complete Story [PDF Format] -
Reinforcing India's role as 'pharmacy of the world' post Covid: Satish Reddy
Click Here for the Complete Story [PDF Format] -
Covid-19 has helped Indian pharma fortify its position: Satish Reddy, Dr Reddy's Chairman
Click Here for the Complete Story [PDF Format] -
Supply chain disruptions on logistics side are over in pharma sector, says Dr Reddy’s CFO, CFO News, ETCFO
Click Here for the Complete Story [PDF Format] -
"Innovation Should Be Given a Boost Through Tax Incentives" - Satish Reddy's interview
Click Here for the Complete Story [PDF Format] -
API package has led to some hope but government involvement is essential ... Policy shift has to be bold and sustained' - Satish Reddy
Click Here for the Complete Story [PDF Format] -
Govt must incentivise pharma exports, drug discovery: Dr Reddy's Chairman. Public spending on healthcare must also be scaled up, says Satish Reddy
-
Covid-19 has been a catalyst for learning transition' - said Archana Bhaskar, CHRO, Dr Reddy’s Laboratories, in an exclusive interview.
Click Here for the Complete Story [PDF Format] -
Post Covid, innovative and agile pharma cos will become stronger: GV Prasad - Interview
Click Here for the Complete Story [PDF Format] -
IPA Chief Satish Reddy: Coronavirus API Supply Impact A ‘Big Wake Up Call’ For India
Click Here for the Complete Story [PDF Format] -
Indian pharma industry: From cultural practices to quality intensive; what lies ahead?
Click Here for the Complete Story [PDF Format] -
Why a New Expat CEO may be Good News for Dr Reddy's
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s Not as Big as it Should be in India..We Want to Grow More
Click Here for the Complete Story [PDF Format]
